3 results match your criteria: "UCLA School of Medicine 90095-1741[Affiliation]"
J Thorac Cardiovasc Surg
February 1997
Division of Cardiothoracic Surgery, UCLA School of Medicine 90095-1741, USA.
Ischemia and reperfusion may damage myocytes and endothelium in jeopardized hearts. This study tested whether (1) endothelial dysfunction (reduced nitric oxide release) exists despite good contractile performance and (2) supplementation of blood cardioplegic solution with nitric oxide precursor L-arginine augments nitric oxide and restores endothelial function. Among 30 Yorkshire-Duroc pigs, 6 received standard glutamate/aspartate blood cardioplegic solution without global ischemia.
View Article and Find Full Text PDFSemin Thorac Cardiovasc Surg
January 1997
Division of Cardiothoracic Surgery, UCLA School of Medicine 90095-1741, USA.
Unlabelled: The purpose of this report is to review our surgical experience with primum atrial septal defect. Since 1982, infants with primum atrial septal defect have undergone complete repair consisting of closure of the cleft of the left atrioventricular valve and atrial septal defect with a pericardial patch. Ages at operation ranged from early neonatal period until 5 years.
View Article and Find Full Text PDFJ Heart Lung Transplant
September 1996
Division of Cardiothoracic Surgery, UCLA School of Medicine 90095-1741, USA.